Climb Bio, Inc.

NASDAQ:CLYM

Biotechnology

Healthcare
$9.78 +0.17%

+$0.02 today

Market cap
$574.46M
Beta
0.10
P/E (TTM)
-14.7
EPS (TTM)
-$0.77
52W Low $1.17High $12.48

Volume 0.59M

Average 0.88M

Price history

Climb Bio, Inc. SEC filings

Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.

Price history

Dividend-adjusted closing price

Period change

+412.04%

Period high

$17.84

Period low

$1.64

Latest

$9.78

SEC filings

What has the company disclosed?

Browse annual, quarterly, and current reports and other filings by form type.

SEC Filings

Recent regulatory filings

FormFiling DateAccepted
SC 13D/ANov 9, 2026Nov 9, 2026
SC 13G/ANov 5, 2026Nov 5, 2026
S-3ASRNov 5, 2026Nov 5, 2026
10-QNov 5, 2026Nov 5, 2026
8-KNov 5, 2026Nov 5, 2026
SC 13GOct 28, 2026Oct 28, 2026
SC 13GOct 27, 2026Oct 27, 2026
8-KOct 26, 2026Oct 26, 2026
8-KOct 23, 2026Oct 23, 2026

Competitors

Who does Climb Bio, Inc. compete with?

Open similar companies to compare their filings and price history.

Questions

Filing questions

Common questions about CLYM's filings, answered from its disclosures.

What is the latest CLYM filing?

The latest filing shown is SC 13D/A dated Nov 9, 2026.

How many recent filings does CLYM have?

Intrinsic Alpha currently shows 9 recent filings for CLYM.